19:41 , Jun 2, 2017 |  BioCentury  |  Product Development

Ears wide open

Based on unmet need alone, hearing loss should have been every bit as attractive to investors and drug developers as ophthalmic diseases, which entered a renaissance in the mid-2000s resulting in a multibillion-dollar market for...
07:00 , May 23, 2011 |  BioCentury  |  Finance

Euro IPOs

Euro IPOs French cancer diagnostic play Median Technologies Inc. and Swedish dermatology company Moberg Derma AB completed IPOs last week, while Dutch molecular diagnostic company Agendia B.V. added itself to the queue. Median raised €10 million ($14.1...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Company News

Genticel board of directors update

Genticel S.A., Labege, France   Business: Cancer, Infectious   Appointed: Alain Munoz, representative of AGF Private Equity   ...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Financial News

Genticel completes venture financing

Genticel S.A., Labege, France   Business: Cancer, Infectious   Date completed: 3/9/10   Type: Venture financing   Raised: €13.1 million ($17.8 million)   Investors: AGF Private Equity; Institut Regional de Developpement Industriel; Amundi Private Equity Funds; InnoBio Fund; Edmond de...
08:00 , Dec 14, 2009 |  BioCentury  |  Finance

Ebb & Flow

Investors in oncology company Gloucester Pharmaceuticals Inc. are looking at a 3.5X-6.5X return on an acquisition by Celgene Corp. (NASDAQ: CELG), making it a model for how to execute in-licensing and keep costs under control. Since...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Financial News

BMD completes venture financing

Biomedical Diagnostics S.A., Marne-la-Vallee, France   Business: Diagnostic   Date completed: 12/1/09   Type: Venture financing   Raised: €3 million ($4.5 million)   Investors: Truffle Capital; AGF Private Equity   ...
08:00 , Dec 22, 2008 |  BC Week In Review  |  Company News

Prosensa board of directors update

Prosensa B.V., Leiden, the Netherlands   Business: Musculoskeletal   Appointed: Jim Van heusden, an executive investment manager at Gimv N.V.; and Remi Droller, an investment director at AGF Private Equity   ...
02:23 , Dec 17, 2008 |  BC Extra  |  Financial News

OncoMethylome raises EUR 8.4 million

Molecular diagnostics company OncoMethylome (Euronext:ONCOB) raised EUR 8.4 million ($11.3 million) through a private placement of 1.3 million shares at EUR 6.29. The deal price is a 4% premium to OncoMethylome's close of EUR 6.05...
08:00 , Nov 24, 2008 |  BC Week In Review  |  Company News

Biotie, elbion deal

BioTie completed its previously announced acquisition of elbion's elbion GmbH subsidiary for about 46.8 million shares valued at €14 million ($17.7 million) based on BioTie's close of €0.30 on Nov. 13, the day before the...
08:00 , Nov 10, 2008 |  BC Week In Review  |  Company News

Biotie, elbion deal

BioTie acquired elbion's elbion GmbH subsidiary for 46.8 million shares valued at €19.2 million ($23.9 million) based on BioTie's close of €0.41 on Oct. 23, the day before the deal was announced. The deal gives...